T0	Drug-Class 37 42	ICIâ€™s
T1	Disease 125 130	tumor
#2	AnnotatorNotes T1	DOID:162
T11	Disease 809 814	tumor
T14	Disease 986 998	osteosarcoma
#4	AnnotatorNotes T14	DOID:3347
T15	Disease 1004 1045	Metastatic, but not primary, osteosarcoma
T17	Disease 1131 1151	primary osteosarcoma
#6	AnnotatorNotes T17	DOID:3347
T19	Disease 1193 1228	primary and metastatic osteosarcoma
#8	AnnotatorNotes T19	DOID:3347
T2	Disease 198 203	tumor
T21	Drug 1298 1307	cisplatin
T23	Disease 1365 1377	osteosarcoma
T24	Disease 1486 1491	tumor
T25	Disease 1597 1602	tumor
T26	Disease 1643 1655	osteosarcoma
T3	Disease 482 487	tumor
T5	Disease 533 538	tumor
T6	Disease 583 588	tumor
T7	Drug-Class 628 631	ICI
T8	Disease 673 678	tumor
T4	Gene-Protein 232 237	PD-L1
#1	AnnotatorNotes T4	HGNC:17635
T9	Gene-Protein 242 247	PD-L2
#9	AnnotatorNotes T9	HGNC:18731
T10	Gene-Protein 330 344	PD-L1/PD-1 mAb
#10	AnnotatorNotes T10	not found
T12	Gene-Protein 435 439	PD-1
#18	AnnotatorNotes T12	HGNC:8760
T13	Gene-Protein 440 445	PD-L1
T16	Biomarker 435 450	PD-1/PD-L1 axis
R1	Association Arg1:T16 Arg2:T3	
T20	Gene-Protein 498 502	PD-1
T22	Gene-Protein 503 508	PD-L1
T27	Gene-Protein 707 712	PD-L1
T28	Gene-Protein 717 722	PD-L2
T29	Gene-Protein 764 769	PD-L1
T30	Gene-Protein 774 779	PD-L2
T31	Biomarker 774 779	PD-L2
#15	AnnotatorNotes T31	D061027
T32	Biomarker 764 769	PD-L1
T33	Collection 764 779	PD-L1 and PD-L2
R4	Association Arg1:T33 Arg2:T11	
#3	AnnotatorNotes T32	D061027
T34	Gene-Protein 949 954	PD-L1
T35	Biomarker 949 970	PD-L1 mRNA expression
R5	Association Arg1:T35 Arg2:T14	
T36	Biomarker 1061 1066	PD-L1
T37	Gene-Protein 1061 1066	PD-L1
#5	AnnotatorNotes T15	DOID:3347
R6	Association Arg1:T36 Arg2:T15	
T38	Gene-Protein 1110 1115	PD-L1
T18	Biomarker 1110 1115	PD-L1
R7	Association Arg1:T18 Arg2:T17	
T39	Gene-Protein 1249 1254	PD-L1
T40	Biomarker 1249 1254	PD-L1
#7	AnnotatorNotes T21	CHEMBL11359
R8	Mediated-Non-Response Arg1:T21 Arg2:T23	
R9	Mediator Arg1:T21 Arg2:T40	
T41	Gene-Protein 1439 1443	PD-L
T42	Gene-Protein 1477 1482	PD-L2
T43	Gene-Protein 1634 1639	PD-L2
T44	Drug-Class 330 352	PD-L1/PD-1 mAb therapy
